Market Size of Europe Healthcare Cold Chain Logistics Industry
| Study Period | 2020-2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 10.40 Billion |
| Market Size (2029) | USD 16.39 Billion |
| CAGR (2024 - 2029) | 9.69 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Healthcare Cold Chain Logistics Market Analysis
The Europe Healthcare Cold Chain Logistics Market size is estimated at USD 10.40 billion in 2024, and is expected to reach USD 16.39 billion by 2029, growing at a CAGR of 9.69% during the forecast period (2024-2029).
A surge in the development and production of biopharmaceutical vaccines and advanced therapies, technological advancement, and the region's interest in R&D have contributed significantly to the market's growth.
During the COVID-19 pandemic, the pharmaceutical industry was one of the most affected sectors, witnessing increased production and supply of vaccines and antidotes worldwide. The United States Department of Transport selected 41 projects to receive around USD 653 million in grants under the Port Infrastructure Development Programme for infrastructure spending for ports and waterways in 2021. Improved temperature-controlled storage facilities at ports for pharmaceutical and other medical products, which require special temperature conditions throughout their journey, were crucial.
The European Medical Agency approves an average of 38 drugs annually, depicting an increase in the development of biopharmaceuticals. The growth in the biopharmaceuticals sector demands advanced requirements for the storage and supply of the products, as regulatory compliance and patient safety are manufacturers' primary concerns.
In 2023, Germany spent USD 8,011 per capita on health, approximately 12.7% of GDP. It is also one of the largest producers and exporters of healthcare products.
